Oncopharmpod
Updates from December 2020
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:19:36
- Mas informaciones
Informações:
Sinopsis
The 1st episode of 2021 covers 5 FDA updates from December 2020 -Pralsetinib for RET-mutated medullary thyroid cancer -The new HER2-targeting margetuximab -Selinexor and the Boston study -Relugolix, an oral GnRH antagonist -Adjuvant osimertinib approved (ADAURA)
